GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $118,000 | -9.9% | 4,931 | -45.0% | 0.00% | 0.0% |
Q4 2020 | $131,000 | +50.6% | 8,967 | +47.0% | 0.00% | 0.0% |
Q3 2020 | $87,000 | -3.3% | 6,102 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $90,000 | +500.0% | 6,102 | +69.6% | 0.00% | – |
Q1 2020 | $15,000 | -11.8% | 3,598 | 0.0% | 0.00% | – |
Q4 2019 | $17,000 | -22.7% | 3,598 | 0.0% | 0.00% | – |
Q3 2019 | $22,000 | -4.3% | 3,598 | 0.0% | 0.00% | – |
Q2 2019 | $23,000 | -11.5% | 3,598 | 0.0% | 0.00% | – |
Q1 2019 | $26,000 | +52.9% | 3,598 | 0.0% | 0.00% | – |
Q4 2018 | $17,000 | -34.6% | 3,598 | 0.0% | 0.00% | – |
Q3 2018 | $26,000 | +225.0% | 3,598 | +192.3% | 0.00% | – |
Q2 2018 | $8,000 | +14.3% | 1,231 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | +40.0% | 1,231 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | -58.3% | 1,231 | 0.0% | 0.00% | – |
Q3 2017 | $12,000 | -20.0% | 1,231 | 0.0% | 0.00% | – |
Q2 2017 | $15,000 | -6.2% | 1,231 | 0.0% | 0.00% | – |
Q1 2017 | $16,000 | +6.7% | 1,231 | 0.0% | 0.00% | – |
Q4 2016 | $15,000 | 0.0% | 1,231 | 0.0% | 0.00% | – |
Q3 2016 | $15,000 | +36.4% | 1,231 | 0.0% | 0.00% | – |
Q2 2016 | $11,000 | +83.3% | 1,231 | 0.0% | 0.00% | – |
Q1 2016 | $6,000 | -40.0% | 1,231 | 0.0% | 0.00% | – |
Q4 2015 | $10,000 | 0.0% | 1,231 | 0.0% | 0.00% | – |
Q3 2015 | $10,000 | – | 1,231 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|